New Study Investigates the Performance of Masimo SpHb® During Acute Bleeding and After Fluid Resuscitation
Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the accuracy and trending of Masimo noninvasive and continuous hemoglobin (SpHb®), referenced to an invasive laboratory hemoglobin (Lab-Hb) measurement, during acute bleeding and after fluid resuscitation.1
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180312005323/en/
Masimo Radical-7® with SpHb®, PVi®, and RD rainbow SET™ Sensor (Photo: Business Wire)
In the study, Dr. Adel and colleagues sought to investigate the performance of SpHb in different volume statuses and perfusion states. They utilized intraoperative data from 70 patients scheduled for major orthopedic procedures with anticipated major blood loss. SpHb, as well as Masimo PVi® and Pi, were measured using a Masimo Radical-7® Pulse CO-Oximeter®. Lab-Hb was measured using a Beckman Coulter LH 750 analyzer. SpHb and Lab-Hb were recorded at three times – a baseline reading five minutes after endotracheal intubation, after major bleeding, and after fluid resuscitation – resulting in 210 time-matched readings, which were divided into fluid responsive and fluid non-responsive samples and low and high perfusion index samples.
Using Bland-Altman analysis, the researchers found “excellent correlation” between Lab-Hb and SpHb (r=0.938). In addition, they reported “excellent accuracy with moderate levels of agreement,” as noted below, for various sample sets:
|Sample set||Mean bias||Limits of agreement|
|All||0.01||-1.33 to 1.34 g/dL|
|Fluid non-responsive||-0.08||-1.27 to 1.11 g/dL|
|Fluid responsive||0.09||-1.36 to 1.54 g/dL|
|High Pi||0.01||-1.34 to 1.31 g/dL|
|Low Pi||0.04||-1.31 to 1.39 g/dL|
The researchers also noted that polar plot analysis (angular bias of -4°) showed “good trending ability for SpHb as a follow-up monitor.”
The investigators concluded that, “SpHb showed excellent correlation with Lab-Hb in fluid responders, fluid non-responders, low-Pi, and high-Pi states. Despite a favorable mean bias of 0.01 g/dL for SpHb, the relatively wide levels of agreement (-1.3 to 1.3 g/dL) might limit its accuracy. SpHb showed good performance as a trend monitor.”
SpHb is not intended to replace laboratory blood testing. Clinical decisions regarding red blood cell transfusions should be based on the clinician’s judgment, considering among other factors: patient condition, continuous SpHb monitoring, and laboratory diagnostic tests using blood samples.
@MasimoInnovates | #Masimo
- Adel A, Awada W, Abdelhamid B, Omar H, Dayem O, Hasanin A, and Rady A. Accuracy and trending of noninvasive hemoglobin measurement during different volume and perfusion statuses. J Clin Mon. 2018. https://doi.org/10.1007/s10877-018-0101-z.
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care. In 1995, the company debuted Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, which has been shown in multiple studies to significantly reduce false alarms and accurately monitor for true alarms. Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates,1 improve CCHD screening in newborns,2 and, when used for continuous monitoring with Masimo Patient SafetyNet™* in post-surgical wards, reduce rapid response activations and costs.3,4,5 Masimo SET® is estimated to be used on more than 100 million patients in leading hospitals and other healthcare settings around the world,6 and is the primary pulse oximetry at 17 of the top 20 hospitals listed in the 2017-18 U.S. News and World Report Best Hospitals Honor Roll.7 In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), and more recently, Oxygen Reserve Index™ (ORi™), in addition to SpO2, pulse rate, and perfusion index (Pi). In 2014, Masimo introduced Root®, an intuitive patient monitoring and connectivity platform with the Masimo Open Connect® (MOC-9®) interface, enabling other companies to augment Root with new features and measurement capabilities. Masimo is also taking an active leadership role in mHealth with products such as the Radius-7® wearable patient monitor, iSpO2 ® pulse oximeter for smartphones, and the MightySat™ fingertip pulse oximeter. Additional information about Masimo and its products may be found at www.masimo.com. Published clinical studies on Masimo products can be found at http://www.masimo.com/cpub/clinical-evidence.htm.
ORi has not received FDA 510(k) clearance and is not available for sale in the United States.
*The use of the trademark Patient SafetyNet is under license from University HealthSystem Consortium.
- Castillo A et al. Prevention of Retinopathy of Prematurity in Preterm Infants through Changes in Clinical Practice and SpO2 Technology. Acta Paediatr. 2011 Feb;100(2):188-92.
- de-Wahl Granelli A et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ. 2009;Jan 8;338.
- Taenzer AH et al. Impact of Pulse Oximetry Surveillance on Rescue Events and Intensive Care Unit Transfers: A Before-And-After Concurrence Study. Anesthesiology. 2010; 112(2):282-287.
- Taenzer AH et al. Postoperative Monitoring – The Dartmouth Experience. Anesthesia Patient Safety Foundation Newsletter. Spring-Summer 2012.
- McGrath SP et al. Surveillance Monitoring Management for General Care Units: Strategy, Design, and Implementation. The Joint Commission Journal on Quality and Patient Safety. 2016 Jul;42(7):293-302.
- Estimate: Masimo data on file.
This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the potential effectiveness of Masimo SpHb®. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions regarding the repeatability of clinical results; risks related to our belief that Masimo's unique noninvasive measurement technologies, including Masimo SpHb, contribute to positive clinical outcomes and patient safety; risks related to our belief that Masimo noninvasive medical breakthroughs provide cost-effective solutions and unique advantages; as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.
Evan Lamb, 949-396-3376
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
The 2018 IDN World Report Findings Show Negative IDN Growth in 201725.9.2018 14:24 | Tiedote
The 2018 IDN World Report findings have been published to idnworldreport.eu. The major findings from the report are: As at December 2017, 7.5 million IDNs were registered, a drop of 14% since December 2016. A major factor in the reduction in global IDN numbers was a change of policy by the Vietnam ccTLD, which resulted in a loss of nearly 1 million .vn second level IDNs. Excluding the impact of .vn, the underlying trend is negative growth of -5%, distributed mainly across second level ccTLDs. IDNs comprise 2% of the world’s domains, a percentage that has remained fairly static since at least 2012. The data in this report include IDNs across both ccTLDs and gTLDs, both at the first and second level. Distribution patterns of IDN registrations are different from those of traditional, ASCII domain names. IDN registrations are highest in Asia and Pacific region. The script of IDNs registered throughout the world strongly correlate to the languages spoken in different countries and territori
Michael Kors Holdings Limited to Be Renamed Capri Holdings Limited25.9.2018 14:00 | Tiedote
Michael Kors Holdings Limited (NYSE:KORS), a global fashion luxury group, announced today that a definitive agreement has been signed to acquire all of the outstanding shares of Italian luxury fashion house Gianni Versace S.p.A. for a total enterprise value of Euro 1.83 billion or approximately US$2.12 billion. Versace, long recognized as one of the world’s leading luxury fashion companies, is synonymous with Italian glamour and style. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180925005557/en/ L-R: Jonathan Akeroyd, Donatella Versace, John D. Idol. (Photo: Rahi Rezvani) John D. Idol, Chairman and Chief Executive Officer of Michael Kors Holdings Limited, said, “The acquisition of Versace is an important milestone for our group. Versace was founded in 1978. For over 40 years, Versace has represented the epitome of Italian fashion luxury, a testament to the brand’s timeless heritage. We are excited to have Versace as part
2018 UL International Crown to Be Staged in Incheon October 4-725.9.2018 13:00 | Tiedote
2018 UL International Crown will be held October 4-7 at Jack Nicklaus Golf Club Korea in Songdo, Incheon Metropolitan City. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180925005024/en/ 2018 UL International Crown will be held October 4-7 at Jack Nicklaus Golf Club Korea in Songdo, Incheon Metropolitan City. Incheon Metropolitan City is not sparing any effort to support the event as an Ambassador Partner. The most high-profile biennial golf tournament on the LPGA Tour, the third UL International Crown to take place with the second held in Chicago in 2016. 32 players from the eight countries will compete in the four-day match-play event for the “Crown.” (Graphic: Business Wire) The most high-profile biennial golf tournament on the LPGA Tour, a first-of-its-kind team match-play competition featuring the best women golfers from the top eight countries around the world, is being played outside the United States for the first t
Abu Dhabi's Fund Agreed Friendly TOB with MINDOL25.9.2018 12:59 | Tiedote
Abu Dhabi Dubai STOB Series 22 Investment Limited Partnership (”AbuDhabi22”as follows) and MINDOL HOLDINGS LIMITED (”MINDOL” as follows) which is listed on the Coinsuper Exchange in Hong Kong (https://www.coinsuper.com) agreed AbuDhabi22 to get 33% of crypto currency MINDOL (MIN)(http://mindol.net) that MINDOL issued by TOB. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180925005523/en/ The world audition of the Hollywood movie "TO DO & DIE" planned to be released worldwide in 2020! (Graphic: Business Wire) Strengthen strategic partnership with MINDOL by implementing TOB. Both of companies chose TOB as strategic approach to make a purchase at a stable price because acquisition price that AbuDhabi22 planned would be expected to significantly exceed with purchases via regular exchanges. TOB STAGE 1 has already finished and now TOB is being implemented at the purchase price of TOB STAGE 2. As a management vision for 2019, MIND
Brentwood Borough Council Stays Ahead of the Game with UniPrint/Azure Cloud Print Solution25.9.2018 12:18 | Tiedote
UniPrint.net announced today their successful secure cloud print deployment with Brentwood Borough Council in Essex, UK. In 2016, the Council released a report entitled “Vision for Brentwood, 2016-2019”. In it, they outlined their goals to better the lives of their constituents, and those goals included reducing costs and streamlining services. After examining their existing infrastructure, they made the decision to become the 1st UK council to move 100% of its systems and infrastructure to the cloud. “We wanted to create a very easy delivery of people’s desktops no matter where they were, whether it was a coffee shop, their home, or one of our sites,” said Tim Huggins, ICT Manager at Brentwood Borough Council. This presented a multitude of challenges, but one of the biggest was printing. “We approached our common provider,” said Huggins. “But it became quite evident very quickly that they had no solution, and we were way ahead of the game with our concepts and what we were trying to d
GSMA Reveals First Details for MWC19 Barcelona25.9.2018 10:00 | Tiedote
The GSMA today announced the first details of MWC19 Barcelona (formerly Mobile World Congress), including keynote speakers, prominent participating companies, programmes and events. MWC19 Barcelona will take place 25-28 February 2019, with events being staged at Fira Gran Via, Fira Montjuïc and La Farga L’Hospitalet. The GSMA expects that more than 107,000 professionals from over 200 countries and territories, representing a wide range of industry sectors, will attend MWC19 Barcelona. Under the event theme of “Intelligent Connectivity”, MWC19 Barcelona will highlight the intersection of “hyper-connectivity”, enabled by 5G and the Internet of Things (IoT), and “intelligence”, delivered by artificial intelligence (AI) and big data. In addition to the core elements of intelligent connectivity, MWC19 will explore the key topics of Content, Digital Trust, Digital Wellness and The Future. “Underpinned by 5G and AI, intelligent connectivity is a major technological force that will shape how t
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme